Toggle Nav
Close
  • Menu
  • Setting

Anti-ERBB2/HER2/CD340 Antibody (Trastuzumab emtansine)

Catalog No.
F1401
Anti-ERBB2/HER2/CD340 Antibody (Trastuzumab emtansine)
Grouped product items
SizePriceStock Qty
100ug
$86.00
Ship with 3-5 days
1mg
$432.00
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Trastuzumab emtansine (Ado-Trastuzumab emtansine) is an antibody-conjugated molecule (ADC) that combines the antitumor properties of the HER2-targeting trastuzumab with the cytotoxic activity of the microtubule inhibitor DM1. Trastuzumab emtansine is being investigated in advanced breast cancer.

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

145 kDa

Shipping

Dry ice

Cas No.

1018448-65-1

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

See label

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

Kadcyla, PRO132365, trastuzumab-MCC-DM1

Buffer System

100 mM Pro 20 mM Arg pH 5.0. No preservative!

Target Accession

P04626

Reactivity

Human

Conjugation

DM1

Clonality

Monoclonal

Isotype

IgG1

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Target

ERBB2 / HER2 / CD340

Note

Please avoid freeze-thaw cycles.